🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 14/09/2022 | 0,6900 USD |
| 14/06/2022 | 0,6900 USD |
| 14/03/2022 | 0,6900 USD |
| 14/12/2021 | 0,6900 USD |
| 14/09/2021 | 0,6500 USD |
| 14/06/2021 | 0,6500 USD |
| 12/03/2021 | 0,6202 USD |
| 14/12/2020 | 0,6202 USD |
| 14/09/2020 | 0,5821 USD |
| 12/06/2020 | 0,5821 USD |
| 13/03/2020 | 0,5821 USD |
| 13/12/2019 | 0,5821 USD |
| 13/09/2019 | 0,5248 USD |
| 14/06/2019 | 0,5248 USD |
| 14/03/2019 | 0,5248 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/01/1989 | 9,54 | 9,66 | 9,48 | 9,60 | +0,83% | 1,88% | 7.676.390 |
| 12/01/1989 | 9,44 | 9,56 | 9,42 | 9,52 | +1,27% | 1,47% | 10.785.178 |
| 11/01/1989 | 9,22 | 9,40 | 9,18 | 9,40 | +2,38% | 2,37% | 4.849.934 |
| 10/01/1989 | 9,26 | 9,28 | 9,10 | 9,18 | -0,43% | 1,93% | 3.556.493 |
| 09/01/1989 | 9,26 | 9,28 | 9,16 | 9,22 | -0,43% | 1,29% | 4.841.760 |
| 06/01/1989 | 9,32 | 9,40 | 9,26 | 9,26 | +0,22% | 1,49% | 7.544.971 |
| 05/01/1989 | 9,16 | 9,26 | 9,12 | 9,24 | +1,31% | 1,52% | 5.339.141 |
| 04/01/1989 | 9,12 | 9,18 | 9,10 | 9,12 | +0,22% | 0,87% | 4.253.203 |
| 03/01/1989 | 9,10 | 9,14 | 8,95 | 9,10 | -0,87% | 2,18% | 4.168.944 |
| 30/12/1988 | 9,16 | 9,20 | 9,14 | 9,18 | +0,65% | 0,65% | 3.373.512 |
| 29/12/1988 | 9,05 | 9,12 | 9,03 | 9,12 | +1,32% | 1,10% | 2.666.741 |
| 28/12/1988 | 9,03 | 9,08 | 9,01 | 9,01 | +0,22% | 0,88% | 2.080.699 |
| 27/12/1988 | 9,06 | 9,06 | 8,99 | 8,99 | -0,88% | 0,88% | 1.866.907 |
| 23/12/1988 | 9,06 | 9,08 | 9,03 | 9,06 | +0,00% | 0,66% | 1.161.394 |
| 22/12/1988 | 9,12 | 9,16 | 9,06 | 9,06 | -0,44% | 1,09% | 2.827.085 |
| 21/12/1988 | 9,20 | 9,22 | 9,05 | 9,10 | -0,87% | 1,94% | 3.356.534 |
| 20/12/1988 | 9,26 | 9,34 | 9,18 | 9,18 | -0,43% | 1,72% | 4.580.808 |
| 19/12/1988 | 9,12 | 9,26 | 9,12 | 9,22 | +0,65% | 1,53% | 4.309.795 |
| 16/12/1988 | 9,16 | 9,16 | 9,06 | 9,16 | +1,32% | 1,08% | 6.465.322 |
| 15/12/1988 | 9,14 | 9,14 | 9,01 | 9,05 | -1,09% | 1,52% | 3.155.318 |
| 14/12/1988 | 9,14 | 9,14 | 9,05 | 9,14 | +0,00% | 1,09% | 3.382.315 |
| 13/12/1988 | 9,06 | 9,22 | 8,95 | 9,14 | +0,66% | 3,07% | 3.338.299 |
| 12/12/1988 | 9,22 | 9,26 | 9,08 | 9,08 | -1,30% | 1,94% | 2.475.586 |
| 09/12/1988 | 9,08 | 9,20 | 9,06 | 9,20 | +1,09% | 1,53% | 2.643.475 |
| 08/12/1988 | 9,16 | 9,18 | 9,10 | 9,10 | -1,08% | 0,87% | 2.412.706 |
| 07/12/1988 | 9,22 | 9,32 | 9,16 | 9,20 | -0,22% | 1,72% | 4.756.243 |
| 06/12/1988 | 9,08 | 9,24 | 9,06 | 9,22 | +1,53% | 1,97% | 4.141.277 |
| 05/12/1988 | 8,99 | 9,12 | 8,97 | 9,08 | +0,66% | 1,77% | 5.275.003 |
| 02/12/1988 | 8,91 | 9,05 | 8,87 | 9,03 | +0,22% | 2,01% | 3.941.318 |
| 01/12/1988 | 8,99 | 9,05 | 8,97 | 9,01 | +0,22% | 0,88% | 3.562.781 |